Project Grant K08AI170918
Award Date
6/17/25
Completion Date
5/31/30
Dollars Obligated
$189K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $729,047 to The Medical College of Wisconsin, Inc. to investigate the GATA2-TGF-β-TAL1 transcriptional pathway and its role in the development and functions of human natural killer (NK) cells. The research aims to uncover the mechanisms by which the GATA2 transcription factor, in interplay with TGF-β1 and TAL1,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $195,894.00 to The Washington University to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function (GOF) syndrome. The primary scientific goal is to investigate critical interactions between T and B cells, as well as the development, polarization, and function of these cells, in order to...
This $256,808 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. The goal of the research is to better define the molecular mechanisms that cause and perpetuate systemic lupus erythematosus (SLE). The project aims to expand analysis of altered mRNA splicing in SLE neutrophils, understand its relation to disease characteristics, and explore...
This Project Grant award of $405,350.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research aims to characterize lipid droplets in macrophage subsets and determine if manipulating lipid droplet content can shift macrophage function, with the goal of uncovering new therapeutic targets for systemic lupus erythematosus (SLE). The award recipient is The...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $520,809 in funding to Rosalind Franklin University of Medicine & Science over the period from September 5, 2024 to August 31, 2029. The overarching goal of this research project is to investigate the role of TAM receptors in modulating the humoral immune response against parasitic infections, such as malaria....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $2,151,847 to The Johns Hopkins University to conduct research on the role of the transcription factor BACH1 as a master regulator of macrophage function and inflammatory response. The proposed research aims to establish BACH1 as a critical modulator of macrophage inflammatory gene expression and subtype specification by...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $229,249 to the University of Washington to investigate the mechanisms through which the enzyme IRG1 and its metabolic product itaconate deplete inflammatory hemophagocytes (IHPCs) to prevent severe anemia. The research aims to elucidate the interactions between IRG1/itaconate and RIPK3 that promote necroptosis in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) totaling $831,755 supports research to investigate the role of lung-resident macrophage subsets, particularly nerve- and airway-associated macrophages (NAMs), in regulating type 2 immune responses and tissue homeostasis. The research aims to elucidate the mechanisms by which these macrophage populations mediate protective...
This $793,093 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research by the Oklahoma Medical Research Foundation to study the regulatory landscape of systemic lupus erythematosus (SLE) and its cardiovascular disease (CVD) comorbidities. The research aims to identify causal genetic variants, target genes, and cell types involved in SLE pathogenesis, with a focus on the role of...
The University of Massachusetts Medical School was awarded a $494,929 Project Grant from the National Institute of Allergy and Infectious Diseases to study the role of Toll-like receptors, type II interferon and type III interferon in a murine model of autoinflammation. The grant will support research exploring the effector mechanisms responsible for inducing and regulating cutaneous lupus using genetically modified mice with discriminating mutations. Specifically, the researchers will use...